Zobrazeno 1 - 10
of 140
pro vyhledávání: '"Dawn B Beaulieu"'
Precision nicotine metabolism-informed care for smoking cessation in Crohn's disease: A pilot study.
Autor:
Elizabeth A Scoville, Hilary A Tindle, Quinn S Wells, Shannon C Peyton, Shelly Gurwara, Stephanie O Pointer, Sara N Horst, David A Schwartz, Dawn W Adams, Matthew S Freiberg, Vanessa Gatskie, Stephen King, Lesa R Abney, Dawn B Beaulieu
Publikováno v:
PLoS ONE, Vol 15, Iss 3, p e0230656 (2020)
IntroductionSmoking is a strong risk factor for disease severity in Crohn's disease (CD) and cessation improves outcomes. The nicotine metabolite ratio (NMR) predicts cessation success with pharmacotherapy: varenicline doubles cessation over nicotine
Externí odkaz:
https://doaj.org/article/3a70b9d4295e41a480d2c2d27ccfe6c2
Autor:
Jia Li, Alan J. Simmons, Caroline V. Hawkins, Sophie Chiron, Marisol A. Ramirez-Solano, Naila Tasneem, Harsimran Kaur, Yanwen Xu, Frank Revetta, Paige N. Vega, Shunxing Bao, Can Cui, Regina N. Tyree, Larry W. Raber, Anna N. Conner, Jennifer M. Pilat, Justin Jacobse, Kara M. McNamara, Margaret M. Allaman, Gabriella A. Raffa, Alain P. Gobert, Mohammad Asim, Jeremy A. Goettel, Yash A. Choksi, Dawn B. Beaulieu, Robin L. Dalal, Sara N. Horst, Baldeep S. Pabla, Yuankai Huo, Bennett A. Landman, Joseph T. Roland, Elizabeth A. Scoville, David A. Schwartz, M. Kay Washington, Yu Shyr, Keith T. Wilson, Lori A. Coburn, Ken S. Lau, Qi Liu
Publikováno v:
Nature Communications, Vol 15, Iss 1, Pp 1-19 (2024)
Abstract Crohn’s disease (CD) is a complex chronic inflammatory disorder with both gastrointestinal and extra-intestinal manifestations associated immune dysregulation. Analyzing 202,359 cells from 170 specimens across 83 patients, we identify a di
Externí odkaz:
https://doaj.org/article/0ba81d63e38741479e8c66302f19cf18
Autor:
Dawn M Wiese, Sara N Horst, Caroline T Brown, Margaret M Allaman, Mallary E Hodges, James C Slaughter, Jennifer P Druce, Dawn B Beaulieu, David A Schwartz, Keith T Wilson, Lori A Coburn
Publikováno v:
PLoS ONE, Vol 11, Iss 5, p e0156387 (2016)
Ulcerative colitis (UC) is associated with increased dietary intake of fat and n-6 polyunsaturated fatty acids (PUFA). Modification of fat metabolism may alter inflammation and disease severity. Our aim was to assess differences in dietary and serum
Externí odkaz:
https://doaj.org/article/3a55dbd4926142afa64672cf0a83947e
Autor:
Lori A Coburn, Sara N Horst, Rupesh Chaturvedi, Caroline T Brown, Margaret M Allaman, Brooks P Scull, Kshipra Singh, M Blanca Piazuelo, Maithili V Chitnavis, Mallary E Hodges, Michael J Rosen, Christopher S Williams, James C Slaughter, Dawn B Beaulieu, David A Schwartz, Keith T Wilson
Publikováno v:
PLoS ONE, Vol 8, Iss 12, p e82300 (2013)
Accurate and high-throughput technologies are needed for identification of new therapeutic targets and for optimizing therapy in inflammatory bowel disease. Our aim was to assess multi-analyte protein-based assays of cytokines/chemokines using Lumine
Externí odkaz:
https://doaj.org/article/d4d7f74ea15f44989f08172ba757ae3f
Autor:
Lauren A. George, Erin Causey, Nisha B. Shah, James C. Slaughter, Jonah Jerabek, Autumn D. Zuckerman, Susan Chhen, Elizabeth Scoville, Robin Dalal, Dawn B. Beaulieu, Baldeep Pabla, David A. Schwartz, Raymond K. Cross, Byron P. Vaughn, Sara Horst
Publikováno v:
Gastro Hep Advances. 2:601-607
Autor:
Sara N. Horst, Robin Dalal, C. Alex Wiles, David A. Schwartz, Dawn B. Beaulieu, Elizabeth A. Scoville, James C. Slaughter, Baldeep S. Pabla
Publikováno v:
Digestive Diseases and Sciences. 67:3129-3137
Vedolizumab is a monoclonal antibody used to treat inflammatory bowel disease (IBD). There is little known about the safety and comparative efficacy of this agent in the elderly population. Here, we present data on the safety and comparative efficacy
Autor:
Thomas M Strobel, Christine Nguyen, Taylor Riggs, Sarah N Horst, Amy Motley, Spencer Upadhyaya, Sarah Campbell, Emily Spring, Robin L Dalal, Elizabeth Scoville, Baldeep Pabla, David A Schwartz, Dawn B Beaulieu
Publikováno v:
Crohn's & Colitis 360. 4
Background A Functional Medicine program was developed at an inflammatory bowel disease (IBD) center with the goal of integrating strategies to address modifiable lifestyle factors and to complete a 6-week elimination diet under the direction of a tr
Autor:
Dawn B. Beaulieu, David A. Schwartz, Elizabeth A. Scoville, Kim Annis, Alexander P. Mamunes, Ailish Garrett, Robin Dalal, Caroline Duley, Sara N. Horst, Mindy Kim, Audrey L. Bennett, Julianne H. Wagnon
Publikováno v:
Inflammatory Bowel Diseases. 28:409-414
Background Prior research demonstrates Crohn’s disease patients often do well in pregnancy; however, less is known about the risk of flare in the postpartum period. Methods A retrospective chart review was conducted at a tertiary care inflammatory
Autor:
Dawn B. Beaulieu, Roman E Gusdorf, Robin Dalal, Austin J. Triana, Kaustav P. Shah, Sara N. Horst, Allison B. McCoy, David A. Schwartz, Baldeep S. Pabla, Elizabeth A. Scoville, Michelle L. Griffith
Publikováno v:
Inflammatory Bowel Diseases. 28:358-363
Background This study evaluated synchronous audiovisual telehealth and audio-only visits for patients with inflammatory bowel disease (IBD) to determine frequency of successful telehealth visits and determine what factors increase the likelihood of c
Autor:
James C. Slaughter, Dawn B. Beaulieu, Miles Basil, Michael F. Vaezi, Tina Higginbotham, Sara N. Horst, Dawn W. Adams, Elizabeth A. Scoville, Robin Dalal, Yash A. Choksi, David A. Schwartz
Publikováno v:
Digestive Diseases and Sciences. 67:639-645
While the pathogenesis of inflammatory bowel disease (IBD) is incompletely understood, disruption of epithelial integrity is suspected to play a prominent role in disease initiation and progression. Currently, there is no convenient way to measure th